FDA Drug Safety Newsletter

The FDA Drug Safety Newsletter, issued from 2007 through 2009, is no longer being published. This publication provided postmarketing information to healthcare professionals to enhance communication of new drug safety information, raise awareness of reported adverse events, and stimulate additional adverse event reporting.

Last Issue: Volume 2, Number 3, 2009   HTML  |  PDF Previous Issues
FDA Drug Safety Newsletter U.S. Food and Drug Administration Center for Drug Evaluation and Research (CDER) 10903 New Hampshire Avenue White Oak Campus,  Silver Spring, MD 20993 Phone: 1-888-INFO-FDA (1-888-463-6332) Health professionals report to: 1-800-FDA-1088 1-800-FDA-0178 (FAX) MedWatch Online Editorial Staff Renan A. Bonnel, PharmD, MPH Gregory D. Busse, PhD Suggestions? We value your comments and please let us know by reaching us at Comments.